Aspen Investment Management Inc Gilead Sciences, Inc. Transaction History

Aspen Investment Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 15, 2019	SELL	$60.54 - $79.0 $158,917 - $207,375	-2,625 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $187,110 - $207,165	2,625 New	2,625 $203,000
Q2 2018 Aug 14, 2018	SELL	$64.88 - $75.68 $178,420 - $208,120	-2,750 Closed	0 $0
Q1 2018 May 16, 2018	BUY	$72.84 - $88.8 $200,310 - $244,200	2,750 New	2,750 $207,000
Q4 2017 Feb 15, 2018	SELL	$71.15 - $83.52 $195,662 - $229,680	-2,750 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$72.11 - $85.47 $198,302 - $235,042	2,750	2,750 $223,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Aspen Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Aspen Investment Management Inc with notifications on news.